IRIS Institutional Research Information System - OPENBS Open Archive UniBS

GOTTI, Daria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 832
EU - Europa 494
AS - Asia 149
AF - Africa 2
OC - Oceania 1
SA - Sud America 1
Totale 1.479
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 832
DE - Germania 227
CN - Cina 98
UA - Ucraina 76
GB - Regno Unito 73
RU - Federazione Russa 48
FI - Finlandia 29
HK - Hong Kong 28
SG - Singapore 19
IE - Irlanda 14
IT - Italia 13
FR - Francia 5
CZ - Repubblica Ceca 3
IN - India 3
RO - Romania 2
AR - Argentina 1
AU - Australia 1
CI - Costa d'Avorio 1
DZ - Algeria 1
HU - Ungheria 1
NL - Olanda 1
PL - Polonia 1
SE - Svezia 1
TW - Taiwan 1
Totale 1.479
Salva come PNG Salva come JPEG
Città #
Fairfield 139
Woodbridge 126
Houston 86
Jacksonville 58
Seattle 56
Ashburn 55
Chandler 47
Cambridge 45
Wilmington 38
Ann Arbor 34
Hong Kong 28
Lancaster 27
Princeton 26
Nanjing 23
Helsinki 18
New York 16
Beijing 14
Dublin 14
Nanchang 13
Singapore 10
Nürnberg 9
Des Moines 8
San Diego 8
Shanghai 7
Brescia 5
Hebei 5
Shenyang 5
Changsha 4
Jinan 4
Boardman 3
Dearborn 3
Hangzhou 3
London 3
Ningbo 3
Tianjin 3
Brno 2
Jiaxing 2
Kunming 2
Lanzhou 2
Milan 2
Taiyuan 2
Taizhou 2
Verona 2
Washington 2
Abidjan 1
Amsterdam 1
Baotou 1
Budapest 1
Buenos Aires 1
Carhaix 1
Changchun 1
Cleveland 1
Clifton 1
Espoo 1
Gunzenhausen 1
Los Angeles 1
Melbourne 1
Monmouth Junction 1
Olomouc 1
Redmond 1
San Mateo 1
Southwark 1
Taipei 1
Warsaw 1
Totale 984
Salva come PNG Salva come JPEG
Nome #
The Disagreement Among Methods to Evaluate Glomerular Filtration Rate in HIV-Infected Patients Naive to Antiretroviral Therapy. 190
Burden of Non-AIDS-Defining and Non-Virus-Related Cancers Among HIV-Infected Patients in the Combined Antiretroviral Therapy Era. 155
A randomized, pilot trial to evaluate glomerular filtration rate by creatinine or cystatin C in naive HIV-infected patients after tenofovir/emtricitabine in combination with atazanavir/ritonavir or efavirenz 143
Evaluation of Liver Fibrosis: Concordance Analysis between Noninvasive Scores (APRI and FIB-4) Evolution and Predictors in a Cohort of HIV-Infected Patients without Hepatitis C and B Infection 142
Prospective evaluation of bone markers, parathormone and 1,25-(OH)2 vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz. 135
Cryptogenic liver diseases: sailing by sight from HIV co-infection with hepatitis viruses to HIV mono-infection through the Pillars of Hercules. 131
Cancer incidence and mortality for all causes in HIV-infected patients over a quarter century: a multicentre cohort study 131
High prevalence of radiological vertebral fractures in HIV-infected males 98
Impact of detectable human cytomegalovirus DNAemia on viro-immunologicaleffectiveness of HAART in HIV-infected patients naive to antiretroviral therapy 97
Increase in Standard Cholesterol and Large HDL Particle Subclasses in Antiretroviral-Naïve Patients Prescribed Efavirenz Compared to Atazanavir/Ritonavir 91
Effects of combined antiretroviral therapy on B- and T-cell release from production sites in long-term treated HIV-1+ patients 83
Exploratory Analysis for the Evaluation of Estimated Glomerular Filtration Rate, Cholesterol and Triglycerides after Switching from Tenofovir/Emtricitabine plus Atazanavir/Ritonavir (ATV/r) to Abacavir/Lamivudine plus ATV/r in Patients with Preserved Renal Function 58
Modulation of regulatory T-cell subsets in very long-term treated aviremic HIV+ patients and untreated viremic patients 47
Reply to van der Pas et al 13
Totale 1.514
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.426
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.426
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020303 0 0 0 51 27 41 39 43 38 43 4 17
2020/2021240 3 29 2 52 25 31 10 21 24 18 18 7
2021/2022121 6 26 0 2 1 3 8 3 3 23 9 37
2022/2023123 13 5 2 3 13 32 0 16 31 1 4 3
2023/2024123 7 5 10 17 3 21 8 4 31 0 0 17
2024/20255 3 1 0 1 0 0 0 0 0 0 0 0
Totale 1.514